FDA Approves First Drug to Treat Low Sexual Desire in Women

The American Sexual Health Association strongly supports the Food and Drug Administration’s (FDA) decision to empower women and their healthcare providers by approving Flibanserin, the first drug to treat low sexual desire in females. Hypoactive sexual desire disorder (HSDD, also known as low sexual desire) is the most commonly reported type of sexual dysfunction in […]